-
1دورية أكاديمية
المؤلفون: Li T; Janssen Global Services, Raritan, New Jersey., Franco-Villalobos C; Evidera, St. Laurent, Quebec, Canada., Proskorovsky I; Evidera, St. Laurent, Quebec, Canada., Sorensen SV; Evidera, Bethesda, Maryland., Tran N; Janssen Research and Development, Los Angeles, California., Sulur G; Janssen Research and Development, Los Angeles, California., Chi KN; BC Cancer-Vancouver Centre, University of British Columbia, Vancouver, British Columbia, Canada.
المصدر: Cancer [Cancer] 2019 Feb 15; Vol. 125 (4), pp. 626-632. Date of Electronic Publication: 2018 Dec 06.
نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Health Resources/*statistics & numerical data , Hospitalization/*statistics & numerical data , Prostatic Neoplasms, Castration-Resistant/*drug therapy, Abiraterone Acetate/administration & dosage ; Androgen Antagonists/administration & dosage ; Double-Blind Method ; Follow-Up Studies ; Humans ; Male ; Prednisone/administration & dosage ; Prognosis ; Prostatic Neoplasms, Castration-Resistant/pathology ; Survival Rate
-
2دورية أكاديمية
المؤلفون: Pal SK; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California., Patel J; Janssen Pharmaceuticals, Spring House, Pennsylvania., He M; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California., Foulk B; Janssen Pharmaceuticals, Spring House, Pennsylvania., Kraft K; Janssen Pharmaceuticals, Spring House, Pennsylvania., Smirnov DA; Janssen Pharmaceuticals, Spring House, Pennsylvania., Twardowski P; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California., Kortylewski M; Department of Cancer Immunotherapeutics and Tumor Immunology, City of Hope Comprehensive Cancer Center, Duarte, California., Bhargava V; Janssen Pharmaceuticals, Spring House, Pennsylvania., Jones JO; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California.
المصدر: Cancer [Cancer] 2018 Mar 15; Vol. 124 (6), pp. 1216-1224. Date of Electronic Publication: 2017 Dec 19.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer
مواضيع طبية MeSH: Androgen Antagonists/*pharmacology , Antineoplastic Combined Chemotherapy Protocols/*pharmacology , Drug Resistance, Neoplasm/*drug effects , Prostatic Neoplasms, Castration-Resistant/*drug therapy , Protein Kinase Inhibitors/*pharmacology, Abiraterone Acetate/pharmacology ; Abiraterone Acetate/therapeutic use ; Aged ; Aged, 80 and over ; Androgen Antagonists/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Benzamides ; Biomarkers, Tumor/blood ; Biomarkers, Tumor/metabolism ; Cyclin D1/metabolism ; Cyclin-Dependent Kinase 4/antagonists & inhibitors ; Cyclin-Dependent Kinase 4/metabolism ; Cyclin-Dependent Kinase 6/antagonists & inhibitors ; Cyclin-Dependent Kinase 6/metabolism ; Humans ; Male ; Middle Aged ; Neoplastic Cells, Circulating/metabolism ; Nitriles ; Phenylthiohydantoin/analogs & derivatives ; Phenylthiohydantoin/pharmacology ; Phenylthiohydantoin/therapeutic use ; Prostatic Neoplasms, Castration-Resistant/blood ; Prostatic Neoplasms, Castration-Resistant/pathology ; Protein Kinase Inhibitors/therapeutic use ; Signal Transduction/drug effects ; Smad3 Protein/metabolism
-
3دورية أكاديمية
المؤلفون: Derosa L; Oncology Unit 2, University Hospital of Pisa, Pisa, Italy., Galli L, Orlandi P, Fioravanti A, Di Desidero T, Fontana A, Antonuzzo A, Biasco E, Farnesi A, Marconcini R, Francia G, Danesi R, Falcone A, Bocci G
المصدر: Cancer [Cancer] 2014 Dec 15; Vol. 120 (24), pp. 3923-31. Date of Electronic Publication: 2014 Aug 08.
نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Antineoplastic Combined Chemotherapy Protocols/*pharmacokinetics , Cyclophosphamide/*administration & dosage , Cyclophosphamide/*pharmacokinetics , Prostatic Neoplasms, Castration-Resistant/*drug therapy , Taxoids/*administration & dosage , Taxoids/*pharmacokinetics, Adenocarcinoma/drug therapy ; Adenocarcinoma/metabolism ; Adenocarcinoma/pathology ; Administration, Metronomic ; Administration, Oral ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cyclophosphamide/adverse effects ; Disease Progression ; Docetaxel ; Humans ; Male ; Middle Aged ; Prostatic Neoplasms, Castration-Resistant/metabolism ; Prostatic Neoplasms, Castration-Resistant/pathology ; Taxoids/adverse effects ; Treatment Outcome
-
4دورية أكاديمية
المؤلفون: Patel JN; Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina., Jiang C, Hertz DL, Mulkey FA, Owzar K, Halabi S, Ratain MJ, Friedman PN, Small EJ, Carducci MA, Mahoney JF, Kelley MJ, Morris MJ, Kelly WK, McLeod HL
المصدر: Cancer [Cancer] 2015 Apr 01; Vol. 121 (7), pp. 1025-31. Date of Electronic Publication: 2014 Nov 21.
نوع المنشور: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Adenocarcinoma/*drug therapy , Antineoplastic Combined Chemotherapy Protocols/*adverse effects , Arteries/*pathology , Prostatic Neoplasms/*drug therapy , Prostatic Neoplasms, Castration-Resistant/*drug therapy , Thromboembolism/*etiology , Venous Thromboembolism/*etiology, Adenocarcinoma/secondary ; Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/administration & dosage ; Bevacizumab ; Clinical Trials, Phase III as Topic ; Docetaxel ; Double-Blind Method ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Staging ; Prednisone/administration & dosage ; Prognosis ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms, Castration-Resistant/secondary ; Survival Rate ; Taxoids/administration & dosage ; Thromboembolism/classification
-
5دورية أكاديمية
المؤلفون: Chow H; Department of Internal Medicine, Division of Hematology/Oncology, University of California Davis, Sacramento, California., Ghosh PM; Department of Biochemistry and Molecular Medicine, University of California Davis, Sacramento, California.; Veterans Affairs Northern California Health Care System-Mather, Mather, California.; Department of Urology, University of California Davis, Sacramento, California., deVere White R; Department of Urology, University of California Davis, Sacramento, California., Evans CP; Department of Urology, University of California Davis, Sacramento, California., Dall'Era MA; Department of Urology, University of California Davis, Sacramento, California., Yap SA; Department of Urology, University of California Davis, Sacramento, California., Li Y; Department of Public Health Sciences, University of California, Davis, California., Beckett LA; Department of Public Health Sciences, University of California, Davis, California., Lara PN Jr; Department of Internal Medicine, Division of Hematology/Oncology, University of California Davis, Sacramento, California., Pan CX; Department of Internal Medicine, Division of Hematology/Oncology, University of California Davis, Sacramento, California.; Veterans Affairs Northern California Health Care System-Mather, Mather, California.; Department of Urology, University of California Davis, Sacramento, California.
المصدر: Cancer [Cancer] 2016 Jun 15; Vol. 122 (12), pp. 1897-904. Date of Electronic Publication: 2016 Mar 28.
نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Prostatic Neoplasms, Castration-Resistant/*drug therapy, Aged ; Aged, 80 and over ; Androgen Antagonists/administration & dosage ; Anilides/administration & dosage ; Everolimus/administration & dosage ; Humans ; Male ; Middle Aged ; Nitriles/administration & dosage ; Receptors, Androgen/metabolism ; TOR Serine-Threonine Kinases/antagonists & inhibitors ; Tosyl Compounds/administration & dosage
-
6Editorial & Opinion
المؤلفون: DeLoughery TG; Division of Hematology and Medical Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, Oregon., Beer TM
المصدر: Cancer [Cancer] 2015 Apr 01; Vol. 121 (7), pp. 975-7. Date of Electronic Publication: 2014 Nov 21.
نوع المنشور: Editorial; Comment
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Adenocarcinoma/*drug therapy , Antineoplastic Combined Chemotherapy Protocols/*adverse effects , Arteries/*pathology , Prostatic Neoplasms/*drug therapy , Prostatic Neoplasms, Castration-Resistant/*drug therapy , Thromboembolism/*etiology , Venous Thromboembolism/*etiology, Humans ; Male
-
7
المؤلفون: Devika Das, Terry Hyslop, Steven R. Patierno, Guru Sonpavde, Bonnie LaCroix, Tian Zhang, Brendon M. Patierno, Julia Rasmussen, Andrew J. Armstrong, A. Oliver Sartor, Patrick Healy, Kouros Owzar, James D. Bearden, Jennifer A. Freedman, Michael Moses Goodman, Kellie Shobe, Matthew I. Milowsky, Mark D. Fleming, Megan Ann McNamara, Michael R. Harrison, Julie Kephart, William R. Berry, Rhonda Wilder, Monika Anand, Carol Winters, Rick A. Kittles, Rhonda L. Bitting, Dadong Zhang, Colleen Riggan, Daniel J. George, Alexander B. Sibley, Elisabeth I. Heath, Susan Halabi
المصدر: Cancer
مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Abiraterone Acetate, Disease-Free Survival, Article, law.invention, 03 medical and health sciences, Prostate cancer, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Prednisone, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Prospective Studies, 030212 general & internal medicine, Prospective cohort study, Retrospective Studies, business.industry, Abiraterone acetate, Prostate-Specific Antigen, medicine.disease, Comorbidity, Hypokalemia, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, Oncology, chemistry, 030220 oncology & carcinogenesis, Hormone therapy, medicine.symptom, business, medicine.drug
-
8
المؤلفون: Sebastien J. Hotte, Shabbir M.H. Alibhai, Aaron R. Hansen, George Tomlinson, Richard Gregg, Urban Emmenegger, Neil Fleshner, Narhari Timilshina, Henriette Breunis, Anthony M. Joshua, Padraig Warde
المصدر: Cancer. 127:2587-2594
مصطلحات موضوعية: Male, Oncology, Canada, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Docetaxel, Targeted therapy, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Nitriles, Humans, Enzalutamide, Medicine, 030212 general & internal medicine, Aged, Chemotherapy, business.industry, Cancer, Geroscience, medicine.disease, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, chemistry, 030220 oncology & carcinogenesis, Toxicity, Androgens, Observational study, business, medicine.drug
-
9
المؤلفون: Irina Proskorovsky, Tracy Li, Giri Sulur, Conrado Franco-Villalobos, Kim N. Chi, Namphuong Tran, Sonja V. Sorensen
المصدر: Cancer. 125:626-632
مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Abiraterone Acetate, Urology, Androgen deprivation therapy, 03 medical and health sciences, symbols.namesake, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Double-Blind Method, Prednisone, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, 030212 general & internal medicine, Poisson regression, business.industry, Abiraterone acetate, Repeated measures design, Androgen Antagonists, Prognosis, medicine.disease, Hospitalization, Survival Rate, Clinical trial, Radiation therapy, Prostatic Neoplasms, Castration-Resistant, Oncology, chemistry, 030220 oncology & carcinogenesis, symbols, Health Resources, business, Follow-Up Studies, medicine.drug
-
10
المؤلفون: Sumanta Kumar, Pal, Jaymala, Patel, Miaoling, He, Brad, Foulk, Katherine, Kraft, Denis A, Smirnov, Przemyslaw, Twardowski, Marcin, Kortylewski, Vipul, Bhargava, Jeremy O, Jones
المصدر: Cancer. 124(6)
مصطلحات موضوعية: Aged, 80 and over, Male, Abiraterone Acetate, Cyclin-Dependent Kinase 4, Androgen Antagonists, Cyclin-Dependent Kinase 6, Middle Aged, Neoplastic Cells, Circulating, Prostatic Neoplasms, Castration-Resistant, Drug Resistance, Neoplasm, Antineoplastic Combined Chemotherapy Protocols, Benzamides, Nitriles, Phenylthiohydantoin, Biomarkers, Tumor, Humans, Cyclin D1, Smad3 Protein, Protein Kinase Inhibitors, Aged, Signal Transduction